Seeking Alpha

SCTPF
  Trillium Therapeutics Inc. - OTCQX

8/21/2014, 3:00 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
SCTPF vs. ETF Alternatives
Company Description
Trillium Therapeutics Inc. is an immuno-oncology company developing innovative therapies for the treatment of cancer. The Company has two premier preclinical programs, SIRPaFc and a CD200 monoclonal antibody (mAb), which target two key immunoregulatory pathways that tumor cells exploit to evade... More
Sector: Services
Country: Canada